London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
TSLA would push TEK into the £'s
If the "Regenerative shock absorber" is worth the slat that they claim.. won awards on the best technology in its class of 2021 then TSLA will be all over it.
Worth holding out for.
Alternatively - Cliff gives himself a fat pay rise while taking pure oxygen eating Crips lol.
Guidant is the one mate... if they didn't have the regenerative shock absorber I would probably sell up to be honest with you - never been overly keen on any of the others and imo the management do some questionable things.
granted the business model is pretty impressive... set up a "Consultancy" company and then branch out your services to university technology and bring them to market.. try and acquire the good ones ?
Cliff pays himself $250k a year which one does question (among other things).
NDA's with advanced car companies... without doubt where the potential lies.
Yes my bad I was referring to shares in issue / % ... their business model is the same for lots of their tech, in that they acquire it and then fund the development off market.. hence why Belluscura is now only 17%.
Last time I contacted Cliff I was cheeky and asked if "someone "like" TESLA were involved in Guident" lol.. trying to catch some hints and as such he passed me on to the PR company... I don't think he will drop any more info than is already in the public domain to be honest with you.
When spoke to him maybe 2 years ago he mentioned that they were looking at investing in CBD / Cannabis but was waiting for the current investments to become self sufficient, shame as he possibly has missed the bubble.
All about guident. imo.
Intrigued to see what comes with Bellusucura and the patents, please let me know your thoughts when more info is out in the open (if it ever is) ... to be honest, as we have both said.. I hope they just sell it on in some manner and reap the 50p per share payout and then put that into the likes of CBD etc they do seem pretty adamant on brining it to market tho so we'll see.
Thanks again for the insight mate muchos gracias.
Any news on here regarding G3E or we total f....D
I will hang on for Guidant news and possible Belluscura IPO anyway
You could be right re modularity so we await further info, but until I see the details it is difficult to know if they are filling a gap. In this regard I received this today following a further email requesting details
Thank you for your email.
I am afraid there is nothing further I can add to what has been already stated in the announcement.
Please note “Belluscura also confirms that it is considering the feasibility and timing of an initial public offering (IPO), and the potential admission to trading on the AIM Market of the London Stock Exchange (or other recognised stock exchange) and expects investments should qualify for Enterprise Investment Scheme (EIS) relief.”
One would expect details relating to the 18 patents to be contained in an Admission Document.
So we'll just have to wait until then.
Re % ownership ...
Today's RNS states
"Tekcapital owns approximately 17.8% (10.5m shares) of Belluscura. ... If all warrants and options are exercised, than Tekcapital would hold approximately 17.1m shares in Belluscura."
Maybe you mixed up the 10M shares with 10% unless I've missed something
Tek has warrants and options for 6.6M shares (at various prices) only 4.8M have the 30 day clause at the highest price.
I would not want them to exercise the 4.8M unless they planned to dump them shortly after IPO unless the detail of the patents is game changing. Either way this could then completely de risk TEK and make them super attractive.
Going through the RNSs it seems that Belluscura started as a wholly owned subsidiary of TEK and has been gradually diluted to 17.8%. I don't know what happened to all the other products listed but the POC's appear Feb 28 2017 with an IPO being talked about in Nov 2017 that seems to have failed by the end of 2017. I am still trying to put a value on the current 10.5M shares but I'm struggling. Do you have an idea?
It might be worth seeing if you can squeeze any more info out of your contact Cliff now that the FDA clearance is through.
I think I might have another dip if this drops below 15 again with an eye to sell on the IPO all other things being equal.
GL and take care
Pantarei suspect we will hear something from Guidant soon.. Almost bang on 6 months since they took on the technology & signed the NDA's.
Pantarei - Brilliant info mate.. really appreciate your opinion & knowledge.
Regarding Modularity I guess this is a positive and could "possibly" be very positive, as perhaps it is built in a way that the components within are independent as opposed to an all in one unit & this is what Belluscura have seen as the gap in the market ?? & if this is patented then surely this would become more attractive.
Wholeheartedly agree regarding bringing it to market... personally I think it would be a very silly decision from a business perspective... imo, either sell it outright or as you say a licencing style setup but don't go down the long winded logisitcs and ballache of bringing it to try and compete with the big boys.
TEK don't currently own 17% mate...
They own around 10% I believe and they have the option to acquire 4.5m warrants at 21p within 30 days of the FDA clearance and options for around 1.5m at 10p and 14p (rough figures - off the top off my head).
Hence why we have seen it drop back today...
Currently have around $100k (imo) so where is that money going to come from ?
I agree re Guidant
Here's my take on Belluscura
"Belluscura has exclusively licensed, acquired or jointly invented 18 patents". I can't find any details or how many and which ones are jointly owned, the % of that ownership and who the partners are. TEK and Belluscura are not forthcoming
"The X-PLO2R POC has patented technology that can deliver up to 95% pure oxygen to patients 24 hours a day, 7 days a week." - Most machines do this
They emphasise weight & modularity
Weight - They claim to have 3 batteries - short mid and long term - the small weight advantage doesn't seem to apply to all 3
Modularity - most of the concentrators in this range are semi modular as the batteries are usually removable. However they claim the sieve beds (the guts of the machine) are modular and replaceable. This IS new. The claim is that this is useful for repair, servicing etc. On the face of it this seems interesting but on closer examination it is not a solution If I told you that next time you put your car in for a service you didn't need to bring the car in, you just needed to send in the engine that still leaves you without a car. So, if you've been prescribed Oxygen 24/7 its not as if you could go a week without it while your sieve beds are away. And the 24/7 devices are serviced annually anyway. Okay so if there was a problem in between times, they could just send you out a spare sieve bed not a whole new machine. But, again, most of the expense is the sieve beds so you might not save much
On the bigger picture, even if these patents are useful, Belluscura would be better licensing or targeting one of the big boys to sell to. There are some very big players here as you would expect in a multi-billion £ market. It is not only about the machines but a whole infrastructure - servicing, repair, spares, accessories, sales and marketing, as well as technicians for the end user that "installs" equipment and "demonstrates" how to use it etc. They also need to be cleared for aircraft use for the US market ideally. The big buyers (NHS Trusts US hospitals etc) with a wide variety of Oxygen needs may not waste time on an unknown one trick pony
I don't know if the tech would attract a significant premium from a buyer as Belluscura only have one product. If they became greedy, It would be easy for the big boys to heavily discount their equivalent product as a loss leader and watch Belluscura burn cash. They could then fight over the bones later. Equally, they might target the partners in the patents, depending on the split, and get it on the cheap that way
All IMHO which could all change with the details of the patents so DYOR
BTW what did TEK pay for the 17%? I 'm trying to calculate the cost to TEK for Belluscura to flop. I took a few at 14.8p just to have an interest but if TEK start piling in I'd need to review. On the other hand, I might increase my holding with a view to sell most on any IPO spike
Well we should hear more about the 13 patents in the near term, along with a road map to listing...
Drop back today was inevitable imo as market wan't to know how it is going to bring it to market & TEK need to find over £1m in the near term to buy their warrants...?????
Cliff said that Belluscura was going to be listed in London this year which will see true value reflected on the share price... Currently (in old valuation terms) it's worth £17m to tek so discounted at market value. Listing imo should see this amount double so would underpin TEK's share at around 40p on Belluscura being listed.
Regarding the patents I am not sure but they have mentioned that the oxygen canisters are refillable / disposable ? Not entirely sure what this means or how unique it is as this is not my domain... that's where you come in ?? :)
For me tho as has been the case all along Guidant is the one that could offer monumental gains and the reason I will remain holding... A regenerative shock absorber and NDA's with listed car companies is worth holding out for... one just hopes TSLA's name gets dropped and we head for the £'s.
I still don’t get this long term. I’ve had no info from Tek/Belluscura re the patents/uniqueness of the tech or even the price point
I took some at 14.5 as I thought this discounted Belluscura.
I await the other investments which seem more promising. It might be good for a trade today I’ll keep a watching brief